Related Experiment Videos
p53-induced p21 controls DNA replication
S Waga1, R Li, B Stillman
1Cold Spring Harbor Laboratory, New York 11724, USA.
Abstract:
The p21 protein, a regulator of cyclin-dependent kinases (CDKs), has been thought to be one of the key proteins to function in cell proliferation suppression upon DNA damage. In normal cells but not in many tumor cells, p21 forms a quaternary complex with a cyclin, a CDK and the proliferating cell nuclear antigen (PCNA), one of the DNA replication and repair factors, suggesting that this complex might play an important role in maintaining the integrity of the genome. Here, we have focused on the p21-PCNA interaction in the context of DNA replication or DNA repair, presenting the data from both in vitro and in vivo studies of the p21 function.
Insights
The p21 protein interacts with proliferating cell nuclear antigen (PCNA) to maintain genome integrity. This interaction is crucial for cell cycle regulation and DNA repair in normal cells, but often disrupted in tumors.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The p21 protein is a key regulator of cyclin-dependent kinases (CDKs) involved in cell proliferation suppression after DNA damage.
- In normal cells, p21 forms a complex with cyclin, CDK, and proliferating cell nuclear antigen (PCNA), a DNA replication and repair factor.
- This quaternary complex is suggested to be vital for maintaining genome integrity.
Purpose of the Study:
- To investigate the interaction between p21 and PCNA.
- To elucidate the role of the p21-PCNA complex in DNA replication and repair.
Main Methods:
- In vitro studies of p21-PCNA interaction.
- In vivo studies of p21 function in the context of DNA replication and repair.
Main Results:
- Data presented from both in vitro and in vivo experiments.
- Focus on the functional significance of the p21-PCNA interaction.
Conclusions:
- The p21-PCNA interaction is a critical mechanism for genome maintenance.
- Understanding this interaction may provide insights into cancer development and therapeutic strategies.